Kawasaki disease: Four case reports of cardiopathy with an institutional and literature review

被引:4
作者
Ashrafi, Amir H.
Wang, Jenny
Stockwell, Christina A.
Lloyd, David
McAlvin, James B.
Russo, Pierre
Shehata, Bahig M.
机构
[1] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA 30332 USA
[2] Childrens Healthcare Atlanta, Dept Pathol, Atlanta, GA 30332 USA
[3] Childrens Healthcare Atlanta, Dept Clin Res, Atlanta, GA 30332 USA
[4] Childrens Healthcare Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
[5] Emory Univ, Dept Pathol, Atlanta, GA 30332 USA
关键词
kawasaki disease; intravenous immune globulin; vascular endothelial growth factor;
D O I
10.2350/06-10-0172.1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Kawasaki disease (KD) is a systemic vasculitis condition with a relatively unknown etiology. First described in 1967 by Tomisaku Kawasaki in Japan, KD has come to be widely diagnosed in every region of the world. The disease has a high prevalence in children ages 6 months to 5 years, particularly in those of Japanese descent. Patients often present with a high fever, rash, lymphadenopathy, and conjunctival injections, but there is no diagnostic test for KD. This paper presents data from our Kawasaki registry including 99 patients with emphasis on Kawasaki cardiopathy. Three patients died from complications of KD, and 1 patient underwent heart transplant for massive aneurysmal dilatation. The 4 explanted hearts showed a spectrum of pathological findings (acute thrombosis, vasculitis, and myocarditis), and I patient showed the long-term sequelae of vasculitis in the form of massive aneurysmal dilatation. Among the survivors, 30% showed aneurysmal dilatation. This paper reviews the most recent information regarding Kawasaki cardiopathy and underlying molecular mechanisms.
引用
收藏
页码:491 / 499
页数:9
相关论文
共 57 条
[11]  
FUJITA Y, 1989, PEDIATRICS, V84, P666
[12]   Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease [J].
Fukazawa, R ;
Sonobe, T ;
Hamamoto, K ;
Hamaoka, K ;
Sakata, K ;
Asano, T ;
Imai, T ;
Kamisago, M ;
Ohkubo, T ;
Uchikoba, Y ;
Ikegami, E ;
Watanabe, M ;
Ogawa, S .
PEDIATRIC RESEARCH, 2004, 56 (04) :597-601
[13]   CD25+ CD4+ regulatory T cells in patients with Kawasaki disease [J].
Furuno, K ;
Yuge, T ;
Kusuhara, K ;
Takada, H ;
Nishio, H ;
Khajoee, V ;
Ohno, T ;
Hara, T .
JOURNAL OF PEDIATRICS, 2004, 145 (03) :385-390
[14]  
Gidding S S, 1987, Prog Clin Biol Res, V250, P305
[15]   Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: Its possible role in progression of coronary artery lesions [J].
Hamamichi, Y ;
Ichida, F ;
Yu, XY ;
Hirono, KI ;
Uese, KI ;
Hashimoto, I ;
Tsubata, S ;
Yoshida, T ;
Futatani, T ;
Kanegane, H ;
Miyawaki, T .
PEDIATRIC RESEARCH, 2001, 49 (01) :74-80
[16]  
HARADA F, 1986, AM J HUM GENET, V39, P537
[17]  
JEANETTE JC, 2002, PEDIATR RES, V53, pA94
[18]   Long-term consequences of Kawasaki disease - A 10- to 21-year follow-up study of 594 patients [J].
Kato, H ;
Sugimura, T ;
Akagi, T ;
Sato, N ;
Hashino, K ;
Maeno, Y ;
Kazue, T ;
Eto, G ;
Yamakawa, R .
CIRCULATION, 1996, 94 (06) :1379-1385
[19]  
Kawasaki T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214
[20]   An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease [J].
Kuniyuki, S ;
Asada, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (02) :303-304